Failure of beta-adrenergic blockade to alter ventricular fibrillation threshold in the dog. Evidence for extra-adrenergic effects of pronethalol.
نویسندگان
چکیده
The effects of two beta-adrenergic blocking agents, pronethalol and propranolol, on ventricular fibrillation thresholds were tested in dogs. Pronethalol (4.0 mg/kg, 5 dogs) produced a mean increase of 45% in the fibrillation threshold. Propranolol (0.4 mg/kg, 7 dogs) failed to produce a significant change of the fibrillation threshold. To examine the possibility that the difference between the responses to pronethalol and propranolol might be related to the difference in dose of the beta-blocking agents, 4.0 mg/kg of propranolol was given to 3 dogs; this dose also failed to produce a consistent change of ventricular fibrillation threshold. These data indicate that under the conditions of our experiments it was possible to block the betaadrenergic receptors with propranolol without producing a change of the ventricular fibrillation threshold. The increase of the fibrillation threshold produced by pronethalol was probably a consequence of its quinidine-like properties rather than of its beta-receptor blockade. ADDITIONAL
منابع مشابه
Failure of Beta-Adrenergic Blockade to Alter Ventricular Fibrillation Threshold in the Dog
The effects of two beta-adrenergic blocking agents, pronethalol and propranolol, on ventricular fibrillation thresholds were tested in dogs. Pronethalol (4.0 mg/kg, 5 dogs) produced a mean increase of 45% in the fibrillation threshold. Propranolol (0.4 mg/kg, 7 dogs) failed to produce a significant change of the fibrillation threshold. To examine the possibility that the difference between the ...
متن کاملPropranolol (inderal) in Persistent Ventricular Fibrillation.
Pronethalol, a beta-adrenergic-blocking agent, has been used successfully in the treatment of supraventricular and ventricular arrhythmias (Stock and Dale, 1963; Grandjean and Rivier, 1963; Johnstone, 1964; Payne and Senfield, 1964). Vaughan Williams and Sekiya (1963) demonstrated that ventricular fibrillation produced in guinea-pigs by the infusion of ouabain could be prevented and controlled ...
متن کاملBeta-adrenergic blockade in the treatment of exercise-induced paroxysmal ventricular tachycardia.
PAROXYSMAL ventricular tachycardia of the type provoked by exertion or excitement is a rare condition well described by Wilson et al. in 1932.1 The circumstances under which paroxysms occur suggest that sympathetic stimuli are important in producing the arrhythmia. Responses to sympathetic stimuli have been classified by Ahlquist as either a-adrenergic or /3-adrenergic.2 Chronotropic and cardia...
متن کاملAcute and chronic effects of an adrenergic beta-receptor blocking agent (propranolol) in treatment of cardiac arrhythmias.
THE INTRODUCTION of the adrenergic beta-receptor blocking agent, pronethalol,1 and the more recent availability of its analogue propranolol2 have served as a new impetus in the pharmacological study of the cardiovascular system. Clinical use of these compounds has been explored in the treatment of hypertension,3 angina pectoris,4 prolonged systemic hypotension,5 hypertrophic subaortic stenosis,...
متن کاملBeta-adrenergic blockade and cardiac arrhythmias.
The evaluation of beta-adrenergic blockade in cardiac arrhythmias is difficult because of the complex nature of the arrhythmias and the varied modes of action of blocking drugs. Studies have confirmed the therapeutic value of the betaadrenergic blocking drug pronethalol (Alderlin) (Vaughan Williams, 1963 ; Stock and Dale, 1963 ; Payne and Senfield, 1964; Wolfson et al., 1966) and its more poten...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation research
دوره 19 4 شماره
صفحات -
تاریخ انتشار 1966